Global Technologies, Ltd Closes on the Acquisition of GOe3, LLC
Parsippany, NJ, March 20, 2024 (GLOBE NEWSWIRE) -- Global Technologies, Ltd. (OTC Pink:GTLL), a company with operations in the acquisition...
Month: March 2024
DocGo Leadership Purchase Shares in Open Market
Contacts Media: DocGo Michael Padovano 5W Public Relations docgo@5wpr.com pr@docgo.com DocGo Investors: Mike Cole DocGo 949-444-1341 mike.cole@docgo.com ir@docgo.com Steve Halper...
Aterian Announces Reverse Stock Split
NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) has announced a 1-for-12...
Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024
GAITHERSBURG, Md., March 20, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it...
AppYea Launches E-Commerce Store on Amazon Broadening Distribution
AppySleep smart wristband now available on Amazon Successful fulfillment of all pre-orders Entering the 17.9 Billion Sleep Tech Device Market...
Clubhouse Media Group, Inc. Announces Rollout of Creator Video Discovery Page on HoneyDrip.com
LOS ANGELES, March 20, 2024 (GLOBE NEWSWIRE) -- Clubhouse Media Group, Inc. (OTC: CMGR) ("CMGR"), a social media firm, today...
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
BRISBANE, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on...
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
LEXINGTON, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection...
Ollie’s Bargain Outlet Holdings, Inc. Reports Fourth Quarter and Fiscal 2023 Financial Results
~ Q4 Net Sales increased 18.0%; Q4 Comparable Store Sales increased 3.9% ~~ Q4 Earnings per Share increased 44.7% to...
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
The exclusive License Agreement grants NLS Pharmaceutics global rights to next-generation non-sulfonamide orexin-1 / orexin-2 receptor agonists, tailored to target...
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
The exclusive License Agreement grants NLS Pharmaceutics global rights to next-generation non-sulfonamide orexin-1 / orexin-2 receptor agonists, tailored to target...
FirstBank Puerto Rico selecciona a nCino para transformar los servicios de préstamos comerciales
SAN JUAN, Puerto Rico, March 20, 2024 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), pionero en banca basada en la...
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
SOUTH SAN FRANCISCO, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and...
Moleculin to Report Full Year 2023 Financial Results on March 22, 2024 and Host Conference Call and Webcast
In-depth discussion of stratification of Company's 2nd line data of Annamycin as a therapy for acute myeloid leukemia (AML) Guidance...
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
Appoints Paul Josephs, an executive with 25 years of CDMO experience as CEO, to succeed current CEO James Hall following...
H World Group Limited Reports Fourth Quarter and Full Year of 2023 Unaudited Financial Results
SINGAPORE and SHANGHAI, China, March 20, 2024 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H...
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PALO ALTO, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...
Aurora Cannabis Achieves Australia’s TGA GMP Certification, Setting Global Standard for Quality and Compliance
Milestone Achievement Signals Company's Commitment to Solidifying its Leadership in the Australian Market ...
Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),...
Health and safety emerges as top risk facing global directors according to WTW’s and Clyde & Co’s latest survey
LONDON, March 20, 2024 (GLOBE NEWSWIRE) -- Health & safety emerges as the top risk for directors and officers according...
Ericsson appoints Andres Vicente Head of Market Area South East Asia, Oceania & India
STOCKHOLM, March 20, 2024 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announces the appointment of Andres Vicente as its new Head...
Recurrent Energy Expands Solar Pipeline in Spain with the Acquisition of a Portfolio exceeding 420 MWp
GUELPH, ON, March 20, 2024 /PRNewswire/ -- Recurrent Energy, a subsidiary of Canadian Solar Inc. ("Canadian Solar") (NASDAQ: CSIQ) and...
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
MINNEAPOLIS, March 20, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated biologics contract development and manufacturing organization...
Beamr Boost for Machine Learning: Accelerating Neural Networks Training
Herzliya Israel, March 20, 2024 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and...
BioLineRx to Report 2023 Annual Financial Results on March 26, 2024
- Management to Hold Conference Call at 08:30 a.m. EDT - TEL AVIV, Israel, March 20, 2024 /PRNewswire/ -- BioLineRx...
BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024
SUNNYVALE, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a developer of cellular and cell-derived therapeutics for the...
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
WATERTOWN, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing...
Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
Contacts Syros Karen Hunady Director of Corporate Communications & Investor Relations 1-857-327-7321 khunady@syros.com Investors Hannah Deresiewicz Stern Investor Relations, Inc....
Sportradar Reports Fourth Quarter and Full Year 2023 Results
Delivered record results, growing revenue 20% and Adjusted EBITDA 33% for fiscal 2023Targeting strong outlook in 2024 of at least...
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
Five specialized treatment centers being qualified across the U.S. to minimize travel burden on eligible patients and their familiesOrchard Assist...
OKYO Pharma to Release New and Comprehensive Data from Phase 2 Dry Eye Disease Trial and Host Key Opinion Leader Event
LONDON and NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
Contacts Investor Contact Kendra Sweeney Vice President, Investor Relations and ESG kendra.sweeney@neogenomics.com Media Contact Andrea Sampson President/CEO, Sampson Public Relations...
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
MARIETTA, Ga., March 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that...
LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results
UTRECHT, The Netherlands and PHILADELPHIA, March 20, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” “the Company”), a...
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
CHASKA, Minn., March 20, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated...
IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENSai™. Contacts IPA: info@ipatherapeutics.com Carterra:...
IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET
TORONTO and GLIL YAM, Israel, March 20, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis",...
Smart Share Global Limited to Report Fourth Quarter and Fiscal Year 2023 Results on March 28, 2024
SHANGHAI, China, March 20, 2024 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer...
ECARX Unveils Multiple Automotive Intelligence Solutions on Tech Day
SHANGHAI, China, March 20, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility...